曲妥珠单抗
乳腺癌
医学
肿瘤科
后天抵抗
癌症研究
癌症
泛素
内科学
生物
遗传学
基因
作者
Yutian Zou,Anli Yang,Bo Chen,Xinpei Deng,Jindong Xie,Danian Dai,Jinhui Zhang,Hailin Tang,Tao Wu,Zhigang Zhou,Xiaoming Xie,Jin Wang
标识
DOI：10.1016/j.drup.2024.101126
摘要
With the wide application of trastuzumab deruxtecan (T-DXd), the survival of HER2-low breast cancer patients is dramatically improved. However, resistance to T-DXd still exists in a subset of patients, and the molecular mechanism remains unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
invisight
DW
科研狗
Yinxb
aajhajkahna
七听
林狗
嘻嘻哈哈
猖狂战神
蓝天
123
璐璐
学术文献互助
xing_xing
OK
pluto
aaaa
学霸业
秦艽
小时
皖公网安备34019202002308
